Adebrelimab

Generic Name
Adebrelimab
Brand Names
-
Drug Type
Biotech
Chemical Formula
-
CAS Number
2247114-85-6
Unique Ingredient Identifier
1XBY50W1OX
Background

Adebrelimab is under investigation in clinical trial NCT03711305 (Study of Carboplatin Plus Etoposide With or Without SHR-1316 in Participants With Untreated Extensive-stage (ES) Small Cell Lung Cancer (SCLC)).

Indication

用于与卡铂和依托泊苷联合用于广泛期小细胞肺癌患者的一线治疗。

Associated Conditions
-
Associated Therapies
-
© Copyright 2024. All Rights Reserved by MedPath